Autoimmune diseases are known to be caused when body’s immune system attacks its own healthy cells by identifying them as foreign. Autoimmune disease may damage or destroy tissues. These diseases can alter the organ growth and/or organ function. There are about eighty types of autoimmune diseases. Certain autoimmune disorders are more prevalent than others like rheumatoid arthritis, inflammatory bowel disease (IBD), Type 1 diabetes, multiple sclerosis, and Systemic Lupus Erythematous (SLE).
Many of the autoimmune diseases have similar symptoms which make them difficult to diagnose. The most common symptoms are fatigue, fever and general malaise (feeling ill). Symptoms worsen during flare-ups (worsening symptoms) and lessen during remission (little or no symptoms). The most common organs and tissues affected are joints, muscles, skin, red blood cells, blood vessels, connective tissue, endocrine glands. Generally, immune system produces antibodies against harmful invaders like viruses, bacteria, parasites, fungi in the body. Diagnosing an autoimmune disease involves identification of the antibodies being produced by the body. Several tests are used to diagnose an autoimmune disease like autoantibody tests, antinuclear antibody tests, complete blood count, C-reactive protein, erythrocyte sedimentation rate, etc.
According to the American Autoimmune Related Diseases Association (AARDA), 50 million Americans are living with autoimmune disease. The National Institute of Health (NIH) has concluded that autoimmune diseases are one of the key reasons for death among women in the U.S. Increasing cases of autoimmune disease and the significant rise in healthcare expenditure have accelerated the market. Increasing lab automation rates with the ability to conduct multiple tests and generate faster results is also projected to boost market growth. Slow retraction time with few standardized tests to over 80 types of autoimmune disease has encouraged automation of laboratories. Growing public awareness for autoimmune diseases is one of the key driving factors for market growth. Furthermore, increase in partnerships between physicians and clinical laboratories also fuel the market. On the other hand, slow turnaround time for autoimmune disease diagnostic test results, high frequency of false positive results are the factors which are slowing down the market.
The global autoimmune disease diagnostic market report analyzes the market size (Revenue US$ million – 2014 to 2021) for market segmentation based on testing methods and their applications (Grave’s disease, Hashimoto’s thyroiditis, multiple sclerosis, rheumatoid arthritis, systemic lupus erythematosus, Type 1 diabetes, etc.) and forecasts growth trends (CAGR% – 2017 to 2021). The geographical segmentation includes North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World. The report also provides the detailed market landscape and profiles of major competitors (Abbott Laboratories, Inc., Beckman Coulter, Inc., bioMérieux SA, Bio-Rad Laboratories, F. Hoffmann-La Roche Ltd., Inova Diagnostics, Inc., Quest Diagnostics, Siemens Healthcare, and SQI Diagnostics, Inc.) in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent acquisitions and alliances.